AGB-374
AGB-374 is an orally active NDUFS7 inhibitor. AGB-374 destabilizes NDUFS7 protein and inhibits oxidative phosphorylation by targeting mitochondrial complex I. AGB-374 reduces MYC protein levels in colon cancer cells in vivo and delays tumor growth in syngeneic mouse models of colon cancer. AGB-374 synergistically enhances the cytotoxicity of copper chelators against cancer cells. AGB-374 cooperates with copper chelators to downregulate MYC and NDUFS7 protein levels in cancer cells. AGB-374 can be used for the research of colon cancer.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C19H27ClF3N3O5S2
- 分子量:534.01
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
AGB-374 (0.12-10 μM; 6 days) exhibits significant cytotoxic synergy with JR4 or JR5 in HCT116, MIA PaCa-2, and PANC-1 cells[1].
AGB-374 (10 μM; 24 h) downregulates NDUFS7 protein levels in HCT116 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HCT116, MIA PaCa-2, and PANC-1 cells
-
Concentration:0, 0.12, 0.37, 1.1, 3.3, 10 μM
-
Incubation Time:6 days
-
Result:Exhibited significant cytotoxic synergy with JR4 or JR5 in HCT116.
-
Cell Line:HCT116 cells
-
Concentration:10 μM
-
Incubation Time:24 h
-
Result:Decreased levels of NDUFS7 protein in HCT116 cells.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c (female, 8-10 weeks old, subcutaneous implantation of CT26 murine colon carcinoma cells)[1]
-
Dosage:25 mg/kg
-
Administration:p.o.; three doses over 48 hours/daily; 15 days
-
Result:Reduced mean relative MYC level/GAPDH to 0.38 in tumor tissue, compared to control mean of 0.96.
Reduced CTR1 protein levels in treated tumors compared to controls, but the reduction was not statistically significant.
Delayed tumor growth significantly.
Reduced mean final tumor weight significantly.
Observed no apparent signs of toxicity, behavioral changes, or body weight alterations throughout the study.
Revealed no microscopic or morphological abnormalities in liver, heart, kidney, and spleen via histopathological analysis.
Reduced MYC protein levels in tumor tissue compared to controls.
化学情報
-
分子量 534.01
-
分子式 C19H27ClF3N3O5S2
-
SMILES
CC(S(=O)(C1=CC=C(C(F)=C1)S(=O)(N2CCN[C@H](C2)C(N3CCC(F)(CC3)F)=O)=O)=O)C.Cl
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)